Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Hutchison MediPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Hutchison MediPharma Limited - Product Pipeline Review - 2014', provides an overview of the Hutchison MediPharma Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Hutchison MediPharma Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Hutchison MediPharma Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Hutchison MediPharma Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Hutchison MediPharma Limited's pipeline products Reasons to buy - Evaluate Hutchison MediPharma Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Hutchison MediPharma Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Hutchison MediPharma Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Hutchison MediPharma Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hutchison MediPharma Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Hutchison MediPharma Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Hutchison MediPharma Limited Snapshot 5 Hutchison MediPharma Limited Overview 5 Key Information 5 Key Facts 5 Hutchison MediPharma Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Hutchison MediPharma Limited - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Hutchison MediPharma Limited - Pipeline Products Glance 11 Hutchison MediPharma Limited - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Hutchison MediPharma Limited - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Hutchison MediPharma Limited - Drug Profiles 14 HMPL-013 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 HMPL-504 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 HMPL-012 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 HMPL-309 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 HMPL-523 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 HMPL-813 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 HM-029 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 HM-032 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 HMA-42 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 HMPL-453 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 HMPL-507 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Hutchison MediPharma Limited - Pipeline Analysis 26 Hutchison MediPharma Limited - Pipeline Products by Target 26 Hutchison MediPharma Limited - Pipeline Products by Route of Administration 28 Hutchison MediPharma Limited - Pipeline Products by Molecule Type 29 Hutchison MediPharma Limited - Pipeline Products by Mechanism of Action 30 Hutchison MediPharma Limited - Recent Pipeline Updates 31 Hutchison MediPharma Limited - Dormant Projects 36 Hutchison MediPharma Limited - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 39 Disclaimer 39
List of Tables Hutchison MediPharma Limited, Key Information 5 Hutchison MediPharma Limited, Key Facts 5 Hutchison MediPharma Limited - Pipeline by Indication, 2014 7 Hutchison MediPharma Limited - Pipeline by Stage of Development, 2014 9 Hutchison MediPharma Limited - Monotherapy Products in Pipeline, 2014 10 Hutchison MediPharma Limited - Phase II, 2014 11 Hutchison MediPharma Limited - Phase I, 2014 12 Hutchison MediPharma Limited - Preclinical, 2014 13 Hutchison MediPharma Limited - Pipeline by Target, 2014 27 Hutchison MediPharma Limited - Pipeline by Route of Administration, 2014 28 Hutchison MediPharma Limited - Pipeline by Molecule Type, 2014 29 Hutchison MediPharma Limited - Pipeline Products by Mechanism of Action, 2014 30 Hutchison MediPharma Limited - Recent Pipeline Updates, 2014 31 Hutchison MediPharma Limited - Dormant Developmental Projects,2014 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.